3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
6
Sarcoma
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Thymus Neoplasms
2
Mesothelioma
2
Adenocarcinoma
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Interventions
Radiosurgery
27
Radiotherapy
17
Magnetic Resonance Spectroscopy
14
Erlotinib Hydrochloride
14
Bevacizumab
13
Pemetrexed
10
Carboplatin
10
pembrolizumab
9
Gefitinib
9
osimertinib
8
icotinib
7
Temozolomide
7
Nivolumab
6
Specimen Handling
5
Paclitaxel
5
Spermine Synthase
4
Mental Status and Dementia Tests
4
Ipilimumab
4
Drug Therapy
4
Cisplatin
4
atezolizumab
3
alectinib
3
aflutinib
3
Radiation
3
Immunotherapy
3
Fluorodeoxyglucose F18
3
regorafenib
2
paclitaxel-Angiopep-2 conjugate
2
motexafin gadolinium
2
epothilone B
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Quality of Life
×
Thoracic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled